Interview with Advanced Medical Isotope Corporation (ADMD) CEO James Katzaroff
By ChemistFrog As an investor in small capitalization healthcare companies, I understand the risks associated with investments in development phase and early marketing phase companies. The risks can be...
View ArticleGalena Biopharma Inc. (NASDAQ:GALE): Behind the Analyst Ratings
By Teresa Dawn Galena Biopharma’s (NASDAQ:GALE) share price has been climbing steadily since the new year — right along with its analyst ratings. Starting 2013 around $1.80, GALE is now trading...
View ArticleAssured Pharmacy (APHY): A Possible New Drug Abuse Deterrence Business Model
By ChemistFrog The healthcare sector provides a diverse group of investment candidates for investors of many types. From the dividend-paying $66.72 billion heavyweight Bristol Myers Squibb Co....
View ArticleMarket Watch: Dramatic Shift to Bearish Sentiment
By Jeff Pierce Not a bull in sight as the markets struggle to keep the rally alive. With all the sentiment exiting the bullish stance, will the market fool all the Zentrader contributors? To keep some...
View ArticleInVivo Therapeutics (NVIV): The Rise from Obscurity to Acceleration in 2013
By ChemistFrog The search for investment prospects in early-stage pharmaceuticals is never-ending with a wide range of company market capitalizations, different types of drugs/devices under development...
View ArticleSanuWave Health Inc. (SNWV) Boosts Long-Term Potential with Short-Term Catalysts
By VFC’s Stock House SANUWAVE Health Inc. (OTC:SNWV), with trial catalysts pending over the near term, has received its fair share of attention during the course of 2013 thus far, but the company’s...
View ArticleDon’t Let These Five Speculative Stock Plays Slip Below The Radar: FPMI,...
By VFC’s Stock House On numerous occasions during the record-breaking rally of 2013 we’ve pointed out the fact that the more speculative and ‘under the radar’ sectors of the investing world are often...
View ArticleSpecialty Pharmacies Offer Solutions — Also For Investors: PMC, BIOS, APHY
By Dutch Trader In 2012, Americans filled more than 4 billion prescriptions at 62,000 retail, mail, and specialty pharmacies. The largest U.S. pharmacies ranked by total prescription you will find in...
View ArticleSirius XM Radio Inc. (NASDAQ:SIRI): Maxim Group Senior Media Analyst John...
By Demian Russian With a new research report, Maxim Group Senior Media Analyst John Tinker weighs in ahead of Sirius XM Radio’s (NASDAQ:SIRI) Q1 earnings release on Tuesday, April 30th. Noting Sirius...
View ArticleSANUWAVE Health (SNWV): Price Consolidation Positions Company For...
By VFC’s Stock House Shares of SANUWAVE Health, Inc. (SNWV) swiftly achieved a near double in price earlier this year as investor anticipation grew in regards to the initiation of a new Phase III trial...
View ArticleBiotech Rally Creates Fertile M&A Ground for Small Caps: OncoSec Medical Inc....
By AlphaVN While I am not personally a huge fan of high risk, high cost-of-capital businesses, I tend to spend a lot of time writing about them. Mining and high-tech are two of the highest...
View ArticlePharmacy Alliances and the Need for Niche Providers: APHY, WAG, ABC, BIOS,...
By AlphaVN With the upcoming overhaul of the U.S. health care market, known as the Affordable Care Act – that’s ObamaCare in common political parlance – it is expected that there will be a drive...
View ArticleArena Pharmaceuticals, Inc. (NASDAQ:ARNA): Belviq Pre-Launch Analysis
By Spencer Osborne The long anticipated launch of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) anti-obesity drug is upon us. On Friday, June 7th, Arena and marketing partner Eisai Co., Ltd. (ESALY) will...
View ArticleCan Stevia Help Soft Drinks Get Past the Obesity and Diabetes Epidemic?...
By Craig Keolanui The worldwide addiction to sugary sweet carbonated beverages has taken its toll on an adoring public, and health experts are starting to raise red flags. Obesity and type-II diabetes...
View ArticleArena Pharmaceuticals (NASDAQ:ARNA) To Make First Post-Launch Presentation
By Spencer Osborne Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and marketing partner Eisai Co., Ltd. (ESALY) launched the anti-obesity drug, Belviq, on June 7th, 2013. Investors are eagerly awaiting some...
View ArticleWeekly Web Trends For Arena Pharmaceuticals (ARNA) And Vivus (VVUS)...
By Spencer Osborne Arena Pharmaceuticals’ (NASDAQ:ARNA) recent launch of the anti-obesity drug Belviq, joining VIVUS (NASDAQ:VVUS), the provider of Qsymia, we now have two companies and can see...
View ArticleAffordable Care Act Will Benefit Drugstores Treating Chronic Illnesses: APHY,...
By Yagmur Kurt Pharmacy stocks have been some of the best performers over the past two years, despite lower overall sales, due to an increase in newly available generics. For example, Costco Wholesale...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS): Web...
By Spencer Osborne We are now entering a phase where Arena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS) are going head to head with the goal of trimming pounds off of the citizens of...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS):...
By Spencer Osborne The head to head battle for obesity pill supremacy is just heating up. Weekly script numbers are telling just part of the story. While the battle at the pharmacy gets the most...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS): Weekly...
By Spencer Osborne Once again it is time to look at the weekly web trends for Arena Pharmaceuticals’ (NASDAQ:ARNA) Belviq and Vivus’ (NASDAQ:VVUS) Qsymia. I post this data weekly as a reference for...
View ArticleChaz Bono Gives Weight Loss Drugs Celebrity Appeal — Arena Pharmaceuticals...
By Spencer Osborne Chaz Bono is famous for several reasons. First and foremost Chaz was born the child of Sonny and Cher. Secondly Chaz was famous for being transgender and undergoing a sex change...
View ArticleWhen Does A Reverse Stock Split Make Sense? (MARA, NOG, VHC, VRNG, AIG, CDE)
By Mobile Guru In the investing community, few things can get an investor’s attention faster than hearing the word “Reverse Split”. This is typically because reverse splits are more often than not...
View ArticleArena Pharmaceuticals Inc. (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS):...
By Spencer Osborne Once again it is time to look at the weekly web trends for Arena’s (ARNA) Belviq and Vivus’ (VVUS) Qsymia. I post this data weekly as a reference for investors. This week I will add...
View ArticleStevia First Corporation (STVF): Stevia Extract’s Hidden Health Benefits...
By George Budwell Stevia is a natural sweetener extracted from the leaves of the South and Central American plant Stevia rebaudiana Bertoni, and has been used as a sugar substitute in Brazil and Japan...
View ArticleSirius XM Radio (NASDAQ:SIRI): Lead Attorney Mark Lebovitch Weighs In On...
By Demian Russian Mark Lebovitch, a Partner at Bernstein Litowitz Berger & Grossmann LLP, will be the special guest on this evening’s Playground Radio program (Tuesday, September 3rd, 8:00 pm...
View Article
